Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy.

Article Details

Citation

Copy to clipboard

Al-Shihabi A, Chawla SP, Hall FL, Gordon EM

Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy.

Mol Ther Oncolytics. 2018 Dec 12;11:122-126. doi: 10.1016/j.omto.2018.11.002. eCollection 2018 Dec 21.

PubMed ID

30581985 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Rexin G